FTC Intervenes In Teva-Amneal Row To Push Patent Delisting
By Bryan Koenig · March 25, 2024, 8:29 PM EDT
The Federal Trade Commission waded into another patent fight Friday with a New Jersey federal court amicus brief targeting the same Teva Pharmaceuticals asthma inhaler patents it has already included in...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login